DrugCite
Search

AMIAS

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Amias Adverse Events Reported to the FDA Over Time

How are Amias adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Amias, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Amias is flagged as the suspect drug causing the adverse event.

Most Common Amias Adverse Events Reported to the FDA

What are the most common Amias adverse events reported to the FDA?

Swollen Tongue
22 (2.8%)
Lip Swelling
21 (2.67%)
Renal Failure
17 (2.16%)
Bulbar Palsy
16 (2.04%)
Myalgia
15 (1.91%)
Ageusia
14 (1.78%)
Anosmia
14 (1.78%)
Dry Eye
14 (1.78%)
Pleural Effusion
14 (1.78%)
Speech Disorder
14 (1.78%)
Glossodynia
13 (1.65%)
Show More Show More
Dysphagia
12 (1.53%)
Insomnia
12 (1.53%)
Oropharyngeal Blistering
12 (1.53%)
Stress
12 (1.53%)
Oral Pain
11 (1.4%)
Cheilitis
10 (1.27%)
Eye Pruritus
10 (1.27%)
Diplopia
8 (1.02%)
Dizziness
8 (1.02%)
Dyspnoea
8 (1.02%)
Lip Disorder
8 (1.02%)
Tongue Blistering
8 (1.02%)
Atrial Fibrillation
7 (.89%)
Pain In Extremity
7 (.89%)
Sepsis
7 (.89%)
Swelling Face
7 (.89%)
Angioedema
6 (.76%)
Coronary Artery Thrombosis
6 (.76%)
Disease Progression
6 (.76%)
Diverticulum
6 (.76%)
Dysphonia
6 (.76%)
Ejection Fraction Decreased
6 (.76%)
Gallbladder Enlargement
6 (.76%)
Hip Arthroplasty
6 (.76%)
Inguinal Hernia
6 (.76%)
Large Intestinal Obstruction
6 (.76%)
Left Atrial Dilatation
6 (.76%)
Lung Adenocarcinoma
6 (.76%)
Mitral Valve Disease
6 (.76%)
Mitral Valve Incompetence
6 (.76%)
Myocardial Infarction
6 (.76%)
Pancreatic Atrophy
6 (.76%)
Peritonitis
6 (.76%)
Pulmonary Arterial Pressure Increas...
6 (.76%)
Renal Atrophy
6 (.76%)
Right Atrial Dilatation
6 (.76%)
Biliary Cirrhosis Primary
5 (.64%)
Cough
5 (.64%)
Heterophoria
5 (.64%)
Intentional Overdose
5 (.64%)
Jaundice
5 (.64%)
Lung Neoplasm Malignant
5 (.64%)
Abasia
4 (.51%)
Cholestasis
4 (.51%)
Drug Interaction
4 (.51%)
Hepatic Cirrhosis
4 (.51%)
Hepatitis
4 (.51%)
Hyponatraemia
4 (.51%)
Jaundice Cholestatic
4 (.51%)
Oropharyngeal Pain
4 (.51%)
Rash
4 (.51%)
Skin Fissures
4 (.51%)
Vomiting
4 (.51%)
Weight Increased
4 (.51%)
Anorexia
3 (.38%)
Cellulitis
3 (.38%)
Confusional State
3 (.38%)
Fatigue
3 (.38%)
Glomerular Filtration Rate Decrease...
3 (.38%)
Gout
3 (.38%)
Grip Strength Decreased
3 (.38%)
Headache
3 (.38%)
Local Swelling
3 (.38%)
Lung Infection
3 (.38%)
Mental Impairment
3 (.38%)
Myopathy
3 (.38%)
Nausea
3 (.38%)
Neuropathy Peripheral
3 (.38%)
Psoriasis
3 (.38%)
Respiratory Distress
3 (.38%)
Urine Colour Abnormal
3 (.38%)
Vasculitic Rash
3 (.38%)
Weight Decreased
3 (.38%)
Wheezing
3 (.38%)
Acute Hepatic Failure
2 (.25%)
Arrhythmia
2 (.25%)
Arthralgia
2 (.25%)
Blood Creatinine Increased
2 (.25%)
Bone Marrow Failure
2 (.25%)
Cholelithiasis
2 (.25%)
Condition Aggravated
2 (.25%)
Conduction Disorder
2 (.25%)
Constipation
2 (.25%)
Dehydration
2 (.25%)
Delusion
2 (.25%)
Dermatitis Bullous
2 (.25%)
Dystonia
2 (.25%)
Eye Pain
2 (.25%)
Eye Swelling
2 (.25%)
Fall
2 (.25%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Amias, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Amias is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Amias

What are the most common Amias adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Amias, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Amias is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Amias According to Those Reporting Adverse Events

Why are people taking Amias, according to those reporting adverse events to the FDA?

Hypertension
115
Product Used For Unknown Indication
13
Drug Use For Unknown Indication
12
Blood Pressure Increased
12
Cardiac Failure
6
Essential Hypertension
3
Show More Show More
Myocardial Ischaemia
2
Cardiac Failure Congestive
2
Ill-defined Disorder
1
Rheumatoid Arthritis
1
Cardiovascular Event Prophylaxis
1
Coronary Artery Disease
1
Renal Failure Chronic
1
Angina Pectoris
1
Aortic Valve Disease
1
Left Ventricular Dysfunction
1

Amias Case Reports

What Amias safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Amias. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Amias.